88IV - PR Newswire Asia's news


Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research SEONGNAM, South Korea , Sept. 7, 2026 /PRNewswire/ -- Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced a major breakthrough ... 2026-09-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ascletis Announces Inclusion in the Hong Kong Stock Connect List under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs HONG KONG , Sept. 7, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that, the ordinary shares of the Company (the "Shares"), which trade on The Stock ... 2026-09-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction Interim MASTRR Registry analysis represents, to Aroa's knowledge, the largest published prospective bioscaffold analysis in in-patient soft tissue reconstruction ... 2026-09-07T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
CART Blood Pressure Monitor Demonstrates Utility in BP Monitoring for AF and Heart Failure Patients - First to demonstrate clinical utility of ring-type BP monitoring in AF and heart failure patients - Highlighted CART blood pressure monitor's multifaceted value, including ESH-based validation and ... 2026-09-07T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
/C O R R E C T I O N -- Wooree Group/ In the news release, Wooree Group Concludes Vitafoods Asia 2026, CEO Ji-yong Yoon Calls for Scientific Validation Standard for Liposome Claims, issued 07-Sep-2026 by Wooree Group over PR Newswire, we are ... 2026-09-07T Banking/Financial Service Biotechnology Medical/Pharmaceuticals
Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals previously ... 2026-09-07T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion SHANGHAI , Sept. 7, 2026 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced an H-share repurchase plan, under ... 2026-09-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
AtomVie Global Radiopharma Celebrates the Grand Opening of its New State-of-the-Art Radiopharmaceutical Manufacturing Facility in Hamilton, Ontario HAMILTON, ON , Sept. 5, 2026 /PRNewswire/ - AtomVie Global Radiopharma (AtomVie), a leading global Contract Development and Manufacturing Organization (CDMO) in the radiopharmaceutical industry, ... 2026-09-05T Biotechnology Medical/Pharmaceuticals
DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES Dimerix successfully enters into non-dilutive facility agreements to access A$34 million [1] with a syndicate of Australian and U.S. independent lenders, including the previously announced initial facility ... 2026-09-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate FDA clearance enables initiation of a Phase 1 clinical trial and advances the first AD2C-generated candidate into clinical development ... 2026-09-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology